| (+)-pilocarpine | increases expression | ISO | RGD:2544 | 6480464 | Pilocarpine results in increased expression of EGR1 mRNA | CTD | PMID:7968354 |
| (+)-pilocarpine | multiple interactions | ISO | RGD:2544 | 6480464 | Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:7968354 |
| (-)-anisomycin | multiple interactions | ISO | RGD:10512 | 6480464 | SB 203580 inhibits the reaction [Anisomycin results in increased expression of EGR1 mRNA] | CTD | PMID:9671412 |
| (-)-anisomycin | increases expression | ISO | RGD:10512 | 6480464 | Anisomycin results in increased expression of EGR1 mRNA | CTD | PMID:9671412 |
| (-)-citrinin | increases expression | EXP | | 6480464 | Citrinin results in increased expression of EGR1 mRNA; more ... | CTD | PMID:19361540 |
| (-)-citrinin | multiple interactions | EXP | | 6480464 | U 0126 inhibits the reaction [Citrinin results in increased expression of EGR1 protein] | CTD | PMID:19361540 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | epigallocatechin gallate inhibits the reaction [potassium chromate(VI) results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:22079256 |
| (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of EGR1 mRNA | CTD | PMID:22079256 |
| (R)-noradrenaline | increases expression | ISO | RGD:2544 | 6480464 | Norepinephrine results in increased expression of EGR1 | CTD | PMID:7905536 |
| (S)-amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Dextroamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:1347779 PMID:11750902 |
| (S)-amphetamine | affects expression | ISO | RGD:2544 | 6480464 | Dextroamphetamine affects the expression of EGR1 mRNA | CTD | PMID:17049170 |
| (S)-amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Dextroamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:11750902 |
| (S)-amphetamine | multiple interactions | ISO | RGD:2544 | 6480464 | [Caffeine co-treated with Dextroamphetamine] affects the expression of EGR1 mRNA | CTD | PMID:16771831 |
| (S)-amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Dextroamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:11750902 PMID:1347779 |
| (S)-amphetamine | multiple interactions | ISO | RGD:2544 | 6480464 | SCH 23390 inhibits the reaction [Dextroamphetamine results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:1347779 |
| (S)-nicotine | increases expression | ISO | RGD:10512 | 6480464 | Nicotine results in increased expression of EGR1 mRNA | CTD | PMID:17456735 |
| (S)-nicotine | decreases expression | ISO | RGD:10512 | 6480464 | Nicotine results in decreased expression of EGR1 mRNA | CTD | PMID:17997037 PMID:21955143 |
| (S)-nicotine | decreases expression | ISO | RGD:10512 | 6480464 | Nicotine results in decreased expression of EGR1 mRNA | CTD | PMID:21955143 PMID:17997037 |
| (S)-nicotine | multiple interactions | ISO | RGD:10512 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of EGR1 mRNA; more ... | CTD | PMID:20230807 |
| (S)-nicotine | decreases expression | ISO | RGD:10512 | 6480464 | Nicotine results in decreased expression of EGR1 mRNA | CTD | PMID:17997037 |
| 1,10-phenanthroline | increases expression | EXP | | 6480464 | 1,10-phenanthroline results in increased expression of EGR1 mRNA | CTD | PMID:19502547 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | decreases expression | ISO | RGD:10512 | 6480464 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of EGR1 mRNA | CTD | PMID:20230807 |
| 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine | multiple interactions | ISO | RGD:10512 | 6480464 | [Nicotine co-treated with 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine] results in decreased expression of EGR1 mRNA; more ... | CTD | PMID:20230807 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:10512 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA | CTD | PMID:15913567 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:10512 | 6480464 | [FGA gene mutant form results in increased susceptibility to 1-Naphthylisothiocyanate] which results in increased expression of EGR1 mRNA | CTD | PMID:21356363 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:2544 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA | CTD | PMID:18364083 more ... |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:10512 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EGR1 protein | CTD | PMID:22094456 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 protein affects the reaction [1-Naphthylisothiocyanate results in increased expression of ITGB6 protein] | CTD | PMID:22094456 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:10512 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA | CTD | PMID:15913567 PMID:22094456 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:2544 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA | CTD | PMID:18590720 PMID:18364083 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:2544 | 6480464 | Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:18590720 |
| 1-naphthyl isothiocyanate | increases expression | ISO | RGD:2544 | 6480464 | 1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA | CTD | PMID:18364083 PMID:18590720 |
| 1-naphthyl isothiocyanate | multiple interactions | ISO | RGD:10512 | 6480464 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] | CTD | PMID:15913567 |
| 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of EGR1 mRNA | CTD | PMID:20170705 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:2544 | 6480464 | Ethinyl Estradiol affects the expression of EGR1 mRNA | CTD | PMID:17351261 PMID:20170705 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2544 | 6480464 | Ethinyl Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:12075121 PMID:16174780 |
| 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:18936297 |
| 17alpha-ethynylestradiol | affects expression | ISO | RGD:2544 | 6480464 | Ethinyl Estradiol affects the expression of EGR1 mRNA | CTD | PMID:20170705 PMID:17351261 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:2544 | 6480464 | Ethinyl Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:16174780 PMID:12075121 |
| 17alpha-ethynylestradiol | decreases expression | ISO | RGD:2544 | 6480464 | Ethinyl Estradiol results in decreased expression of EGR1 mRNA | CTD | PMID:12655037 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:19153601 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | N-(phosphonomethyl)glycine trimethylsulfonium salt promotes the reaction [Estradiol results in decreased expression of EGR1 mRNA] | CTD | PMID:17984146 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of EGR1 mRNA | CTD | PMID:17984146 PMID:19167446 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:19153601 PMID:23019147 |
| 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of EGR1 mRNA | CTD | PMID:19167446 |
| 17beta-estradiol | increases expression | ISO | RGD:2544 | 6480464 | Estradiol results in increased expression of EGR1 mRNA alternative form | CTD | PMID:8344219 |
| 17beta-estradiol | increases expression | ISO | RGD:2544 | 6480464 | Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:1717835 |
| 17beta-estradiol | multiple interactions | ISO | RGD:2544 | 6480464 | Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA] | CTD | PMID:1717835 |
| 17beta-estradiol | increases expression | ISO | RGD:10512 | 6480464 | Estradiol results in increased expression of EGR1 mRNA | CTD | PMID:14664709 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of EGR1 mRNA | CTD | PMID:17404688 |
| 17beta-estradiol | affects expression | ISO | RGD:10512 | 6480464 | Estradiol affects the expression of EGR1 mRNA | CTD | PMID:15598610 |
| 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | RGD:10512 | 6480464 | Dihydrotestosterone results in increased expression of EGR1 mRNA | CTD | PMID:17023530 |
| 2,2',4,4',5,5'-hexachlorobiphenyl | increases expression | ISO | RGD:2544 | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl results in increased expression of EGR1 mRNA | CTD | PMID:20959002 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases degradation | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased degradation of EGR1 mRNA | CTD | PMID:15342960 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2544 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:20959002 PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10512 | 6480464 | Tetrachlorodibenzodioxin affects the expression of EGR1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EGR1 mRNA | CTD | PMID:16039398 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:2544 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:21215274 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:2544 | 6480464 | Tetrachlorodibenzodioxin affects the expression of EGR1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of EGR1 mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:15056799 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EGR1 mRNA | CTD | PMID:16039398 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10512 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:19770486 PMID:16962184 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:16697128 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10512 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:16962184 PMID:19770486 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:12377990 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 protein | CTD | PMID:15342960 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10512 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:16962184 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of EGR1 mRNA | CTD | PMID:15056799 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of EGR1 mRNA | CTD | PMID:20106945 PMID:16039398 |
| 2,4,6-trinitrotoluene | affects expression | ISO | RGD:2544 | 6480464 | Trinitrotoluene affects the expression of EGR1 mRNA | CTD | PMID:21346803 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:2544 | 6480464 | 2,4-dinitrotoluene affects the expression of EGR1 mRNA | CTD | PMID:21346803 |
| 2,6-dichloroindophenol | multiple interactions | EXP | | 6480464 | [2,6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of EGR1 mRNA | CTD | PMID:21034357 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:2544 | 6480464 | 2,6-dinitrotoluene affects the expression of EGR1 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | ISO | RGD:2544 | 6480464 | 2-Acetylaminofluorene results in increased expression of EGR1 mRNA | CTD | PMID:19167416 |
| 2-butoxyethanol | decreases expression | ISO | RGD:10512 | 6480464 | n-butoxyethanol results in decreased expression of EGR1 mRNA | CTD | PMID:19812364 |
| 2-butoxyethanol | increases expression | ISO | RGD:10512 | 6480464 | n-butoxyethanol results in increased expression of EGR1 mRNA | CTD | PMID:19812364 |
| 2-methylcholine | affects expression | EXP | | 6480464 | beta-methylcholine affects the expression of EGR1 mRNA | CTD | PMID:21179406 |
| 3',5'-cyclic AMP | multiple interactions | ISO | RGD:10512 | 6480464 | [[Eugenol results in increased activity of OLFR73 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA | CTD | PMID:12767924 |
| 3,3',4,4',5-pentachlorobiphenyl | increases expression | ISO | RGD:2544 | 6480464 | 3,4,5,3',4'-pentachlorobiphenyl results in increased expression of EGR1 mRNA | CTD | PMID:20959002 |
| 3,4-methylenedioxymethamphetamine | decreases expression | ISO | RGD:10512 | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of EGR1 mRNA | CTD | PMID:20188158 |
| 3-chloropropane-1,2-diol | increases expression | ISO | RGD:2544 | 6480464 | alpha-Chlorohydrin results in increased expression of EGR1 mRNA | CTD | PMID:14644096 |
| 3H-1,2-dithiole-3-thione | decreases expression | ISO | RGD:2544 | 6480464 | 1,2-dithiol-3-thione results in decreased expression of EGR1 mRNA | CTD | PMID:19162173 |
| 4,4'-diaminodiphenylmethane | increases expression | ISO | RGD:10512 | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of EGR1 mRNA | CTD | PMID:18648102 |
| 4-hydroperoxycyclophosphamide | decreases expression | ISO | RGD:10512 | 6480464 | perfosfamide results in decreased expression of EGR1 mRNA | CTD | PMID:19429390 |
| 4-nitrotoluene | increases expression | ISO | RGD:10512 | 6480464 | 4-nitrotoluene results in increased expression of EGR1 mRNA | CTD | PMID:15618236 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of EGR1 mRNA | CTD | PMID:21856257 |
| 5-fluorouracil | multiple interactions | EXP | | 6480464 | EGR1 protein affects the reaction [Fluorouracil results in increased expression of THBS1 mRNA]; more ... | CTD | PMID:18757417 |
| 5-fluorouracil | affects expression | EXP | | 6480464 | Fluorouracil affects the expression of EGR1 mRNA | CTD | PMID:15205334 PMID:16557594 |
| 5-fluorouracil | affects localization | EXP | | 6480464 | Fluorouracil affects the localization of EGR1 protein | CTD | PMID:18757417 |
| 5-fluorouracil | increases expression | EXP | | 6480464 | Fluorouracil results in increased expression of EGR1 mRNA | CTD | PMID:18757417 |
| 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of EGR1 mRNA | CTD | PMID:17039268 |
| 5-fluorouracil | affects expression | EXP | | 6480464 | Fluorouracil affects the expression of EGR1 mRNA | CTD | PMID:16557594 PMID:15205334 |
| 8-bromo-3',5'-cyclic AMP | increases expression | EXP | | 6480464 | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of EGR1 mRNA | CTD | PMID:22079614 |
| acetaldehyde | increases expression | EXP | | 6480464 | Acetaldehyde results in increased expression of EGR1 mRNA | CTD | PMID:23416264 |
| acetylsalicylic acid | increases expression | ISO | RGD:2544 | 6480464 | Aspirin results in increased expression of EGR1 mRNA | CTD | PMID:12800193 |
| acrolein | increases expression | EXP | | 6480464 | Acrolein results in increased expression of EGR1 mRNA; more ... | CTD | PMID:20015449 |
| acrolein | increases expression | ISO | RGD:10512 | 6480464 | Acrolein results in increased expression of EGR1 mRNA | CTD | PMID:18515264 |
| actinomycin D | multiple interactions | ISO | RGD:2544 | 6480464 | Dactinomycin inhibits the reaction [Estradiol results in increased expression of EGR1 mRNA] | CTD | PMID:1717835 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of EGR1 mRNA | CTD | PMID:21527772 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of EGR1 mRNA | CTD | PMID:21527772 PMID:21641981 |
| aflatoxin B1 | increases expression | ISO | RGD:10512 | 6480464 | Aflatoxin B1 results in increased expression of EGR1 mRNA | CTD | PMID:19770486 |
| aflatoxin B1 | affects expression | EXP | | 6480464 | Aflatoxin B1 affects the expression of EGR1 protein | CTD | PMID:20106945 |
| all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of EGR1 mRNA | CTD | PMID:16012519 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:10512 | 6480464 | Tretinoin promotes the reaction [arsenic trioxide results in increased expression of EGR1 mRNA] | CTD | PMID:15688020 |
| amiodarone | increases expression | EXP | | 6480464 | Amiodarone results in increased expression of EGR1 mRNA | CTD | PMID:19774075 |
| ammonium chloride | affects expression | ISO | RGD:2544 | 6480464 | Ammonium Chloride affects the expression of EGR1 mRNA | CTD | PMID:16483693 |
| amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Amphetamine results in increased expression of EGR1 mRNA | CTD | PMID:12638131 more ... |
| amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Amphetamine results in increased expression of EGR1 mRNA | CTD | PMID:10098858 more ... |
| amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Amphetamine results in increased expression of EGR1 mRNA | CTD | PMID:10098858 more ... |
| amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Amphetamine results in increased expression of EGR1 mRNA | CTD | PMID:15673443 more ... |
| amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Amphetamine results in increased expression of EGR1 mRNA | CTD | PMID:15010207 more ... |
| amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Amphetamine results in increased expression of EGR1 mRNA | CTD | PMID:15673443 more ... |
| amphetamine | multiple interactions | ISO | RGD:2544 | 6480464 | Methylphenidate promotes the reaction [Amphetamine results in increased expression of EGR1 mRNA] | CTD | PMID:20020108 |
| amphetamine | increases expression | ISO | RGD:2544 | 6480464 | Amphetamine results in increased expression of EGR1 mRNA | CTD | PMID:10683413 more ... |
| amphetamine | decreases expression | ISO | RGD:2544 | 6480464 | Amphetamine results in decreased expression of EGR1 mRNA | CTD | PMID:15183010 |
| amphetamine | affects expression | ISO | RGD:2544 | 6480464 | Amphetamine affects the expression of EGR1 mRNA | CTD | PMID:15496936 |
| arachidonic acid | increases expression | EXP | | 6480464 | Arachidonic Acid results in increased expression of EGR1 mRNA | CTD | PMID:16704987 |
| arachidonic acid | increases expression | ISO | RGD:10512 | 6480464 | Arachidonic Acid results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of EGR1 mRNA | CTD | PMID:18039032 |
| ATP | multiple interactions | ISO | RGD:2544 | 6480464 | Iodoacetates inhibits the reaction [Adenosine Triphosphate results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:10723097 |
| ATP | increases expression | ISO | RGD:2544 | 6480464 | Adenosine Triphosphate results in increased expression of EGR1 mRNA | CTD | PMID:10723097 |
| atropine | multiple interactions | ISO | RGD:2544 | 6480464 | Atropine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA] | CTD | PMID:7968354 |
| benzene | decreases expression | ISO | RGD:10512 | 6480464 | Benzene results in decreased expression of EGR1 mRNA | CTD | PMID:15120971 PMID:15122651 |
| benzene | increases expression | EXP | | 6480464 | Benzene results in increased expression of EGR1 mRNA | CTD | PMID:21843810 |
| benzene | decreases expression | ISO | RGD:10512 | 6480464 | Benzene results in decreased expression of EGR1 mRNA | CTD | PMID:15122651 PMID:15120971 |
| benzene | multiple interactions | ISO | RGD:2544 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of EGR1 mRNA | CTD | PMID:17905399 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of EGR1 mRNA | CTD | PMID:15808406 |
| benzo[a]pyrene | increases expression | ISO | RGD:10512 | 6480464 | Benzo(a)pyrene results in increased expression of EGR1 mRNA | CTD | PMID:21569818 PMID:21964900 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of EGR1 mRNA | CTD | PMID:21632981 PMID:21714911 |
| benzo[a]pyrene | increases expression | ISO | RGD:10512 | 6480464 | Benzo(a)pyrene results in increased expression of EGR1 mRNA | CTD | PMID:21569818 |
| benzo[a]pyrene | decreases expression | ISO | RGD:10512 | 6480464 | Benzo(a)pyrene results in decreased expression of EGR1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of EGR1 protein | CTD | PMID:15342960 |
| benzo[a]pyrene | affects activity | EXP | | 6480464 | Benzo(a)pyrene affects the activity of EGR1 protein | CTD | PMID:20624995 |
| bis(2-chloroethyl) sulfide | increases expression | ISO | RGD:10512 | 6480464 | Mustard Gas results in increased expression of EGR1 mRNA | CTD | PMID:18955075 |
| bis(2-ethylhexyl) phthalate | decreases expression | ISO | RGD:10512 | 6480464 | Diethylhexyl Phthalate results in decreased expression of EGR1 mRNA | CTD | PMID:19850644 |
| bis(2-ethylhexyl) phthalate | increases expression | ISO | RGD:2544 | 6480464 | Diethylhexyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:15728792 |
| bis(2-ethylhexyl) phthalate | multiple interactions | ISO | RGD:10512 | 6480464 | PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of EGR1 mRNA] | CTD | PMID:19850644 |
| bisphenol A | affects expression | EXP | | 6480464 | bisphenol A affects the expression of EGR1 mRNA | CTD | PMID:20170705 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of EGR1 protein | CTD | PMID:22552965 |
| bisphenol A | multiple interactions | EXP | | 6480464 | GPER mRNA affects the reaction [bisphenol A results in increased expression of EGR1 protein] | CTD | PMID:22552965 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of EGR1 mRNA | CTD | PMID:22552965 PMID:23019147 |
| bisphenol A | increases expression | ISO | RGD:2544 | 6480464 | bisphenol A results in increased expression of EGR1 mRNA | CTD | PMID:12075121 |
| bleomycin A2 | increases expression | ISO | RGD:10512 | 6480464 | Bleomycin results in increased expression of EGR1 mRNA | CTD | PMID:19147827 |
| bleomycin A2 | multiple interactions | ISO | RGD:10512 | 6480464 | rosiglitazone inhibits the reaction [Bleomycin results in increased expression of EGR1 mRNA] | CTD | PMID:19147827 |
| butyric acid | increases expression | ISO | RGD:2544 | 6480464 | Butyric Acid results in increased expression of EGR1 mRNA | CTD | PMID:12800193 |
| cadmium atom | decreases expression | EXP | | 6480464 | Cadmium results in decreased expression of EGR1 mRNA | CTD | PMID:16439709 |
| cadmium atom | affects expression | EXP | | 6480464 | Cadmium affects the expression of EGR1 mRNA | CTD | PMID:21694771 |
| cadmium dichloride | increases expression | ISO | RGD:2544 | 6480464 | Cadmium Chloride results in increased expression of EGR1 mRNA | CTD | PMID:19010381 |
| cadmium dichloride | increases expression | ISO | RGD:10512 | 6480464 | Cadmium Chloride results in increased expression of EGR1 mRNA | CTD | PMID:15501611 |
| cadmium dichloride | multiple interactions | ISO | RGD:2544 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:19010381 |
| cadmium dichloride | increases methylation | ISO | RGD:2544 | 6480464 | Cadmium Chloride results in increased methylation of EGR1 promoter | CTD | PMID:22457795 |
| cadmium dichloride | multiple interactions | ISO | RGD:10512 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EGR1 mRNA | CTD | PMID:19840844 |
| caffeine | increases expression | ISO | RGD:10512 | 6480464 | Caffeine results in increased expression of EGR1 mRNA | CTD | PMID:10971643 |
| caffeine | decreases expression | ISO | RGD:2544 | 6480464 | Caffeine results in decreased expression of EGR1 mRNA | CTD | PMID:16771831 |
| caffeine | multiple interactions | ISO | RGD:10512 | 6480464 | [Cocaine co-treated with Caffeine] results in increased expression of EGR1 mRNA; more ... | CTD | PMID:10971643 |
| caffeine | multiple interactions | ISO | RGD:2544 | 6480464 | [Caffeine co-treated with Dextroamphetamine] affects the expression of EGR1 mRNA | CTD | PMID:16771831 |
| calcitriol | increases expression | EXP | | 6480464 | Calcitriol results in increased expression of EGR1 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of EGR1 mRNA | CTD | PMID:21592394 |
| calcium atom | multiple interactions | EXP | | 6480464 | [[CXCL9 protein binds to and results in increased activity of CXCR3 protein] which results in increased abundance of Calcium] which results in increased expression of EGR1 mRNA; more ... | CTD | PMID:12517959 |
| calcium(0) | multiple interactions | EXP | | 6480464 | [[CXCL9 protein binds to and results in increased activity of CXCR3 protein] which results in increased abundance of Calcium] which results in increased expression of EGR1 mRNA; more ... | CTD | PMID:12517959 |
| capsaicin | increases expression | ISO | RGD:2544 | 6480464 | Capsaicin results in increased expression of EGR1 mRNA | CTD | PMID:20349343 |
| carbon monoxide | multiple interactions | ISO | RGD:10512 | 6480464 | Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of EGR1 protein]; more ... | CTD | PMID:22046279 |
| carbonyl sulfide | decreases expression | ISO | RGD:2544 | 6480464 | carbonyl sulfide results in decreased expression of EGR1 mRNA | CTD | PMID:19395590 |
| carrageenan | increases expression | EXP | | 6480464 | Carrageenan results in increased expression of EGR1 protein | CTD | PMID:22561171 |
| carrageenan | multiple interactions | EXP | | 6480464 | 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [Carrageenan results in increased expression of EGR1 protein]; more ... | CTD | PMID:22561171 |
| cefaloridine | decreases expression | ISO | RGD:2544 | 6480464 | Cephaloridine results in decreased expression of EGR1 mRNA | CTD | PMID:18500788 |
| chenodeoxycholic acid | increases expression | ISO | RGD:10512 | 6480464 | Chenodeoxycholic Acid results in increased expression of EGR1 mRNA; more ... | CTD | PMID:19931294 |
| chenodeoxycholic acid | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 promotes the reaction [Chenodeoxycholic Acid results in increased expression of SERPINE1 mRNA]; more ... | CTD | PMID:21224055 |
| chenodeoxycholic acid | increases expression | ISO | RGD:10512 | 6480464 | Chenodeoxycholic Acid results in increased expression of EGR1 mRNA; more ... | CTD | PMID:19931294 PMID:21224055 |
| chenodeoxycholic acid | multiple interactions | ISO | RGD:10512 | 6480464 | SL 327 inhibits the reaction [Chenodeoxycholic Acid results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:19931294 |
| chloroprene | decreases expression | ISO | RGD:10512 | 6480464 | Chloroprene results in decreased expression of EGR1 mRNA | CTD | PMID:23125180 |
| chlorpromazine | increases expression | ISO | RGD:2544 | 6480464 | Chlorpromazine results in increased expression of EGR1 | CTD | PMID:20368687 |
| chlorpromazine | multiple interactions | ISO | RGD:2544 | 6480464 | [EGR1 binds to CDKN1A promoter] promotes the reaction [Chlorpromazine results in increased expression of CDKN1A mRNA]; more ... | CTD | PMID:20368687 |
| choline | increases expression | ISO | RGD:2544 | 6480464 | Choline results in increased expression of EGR1 mRNA; more ... | CTD | PMID:17264169 |
| choline | multiple interactions | ISO | RGD:10512 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EGR1 gene | CTD | PMID:20938992 |
| ciguatoxin CTX1B | affects expression | ISO | RGD:10512 | 6480464 | Ciguatoxins affects the expression of EGR1 mRNA | CTD | PMID:18353800 |
| cisplatin | multiple interactions | EXP | | 6480464 | EGR1 protein promotes the reaction [Cisplatin results in increased activity of CASP9 protein] | CTD | PMID:21271225 |
| cisplatin | increases expression | ISO | RGD:10512 | 6480464 | Cisplatin results in increased expression of EGR1 mRNA | CTD | PMID:21151649 |
| cisplatin | increases response to substance | EXP | | 6480464 | EGR1 protein results in increased susceptibility to Cisplatin | CTD | PMID:21271225 |
| clofibrate | multiple interactions | ISO | RGD:10512 | 6480464 | PPARA protein affects the reaction [Clofibrate results in decreased expression of EGR1 mRNA]; more ... | CTD | PMID:17585979 |
| clofibrate | decreases expression | ISO | RGD:2544 | 6480464 | Clofibrate results in decreased expression of EGR1 mRNA | CTD | PMID:15033592 |
| clofibrate | increases expression | ISO | RGD:10512 | 6480464 | Clofibrate analog results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
| clofibrate | increases expression | ISO | RGD:2544 | 6480464 | Clofibrate results in increased expression of EGR1 mRNA | CTD | PMID:15585944 |
| clozapine | decreases expression | ISO | RGD:2544 | 6480464 | Clozapine results in decreased expression of EGR1 mRNA | CTD | PMID:18208916 |
| clozapine | decreases expression | ISO | RGD:2544 | 6480464 | Clozapine results in decreased expression of EGR1 protein | CTD | PMID:17028028 |
| cocaine | affects expression | ISO | RGD:10512 | 6480464 | Cocaine affects the expression of EGR1 mRNA | CTD | PMID:18355967 |
| cocaine | increases expression | ISO | RGD:2544 | 6480464 | Cocaine results in increased expression of EGR1 mRNA | CTD | PMID:11860464 more ... |
| cocaine | increases expression | ISO | RGD:2544 | 6480464 | Cocaine results in increased expression of EGR1 mRNA | CTD | PMID:1347779 more ... |
| cocaine | affects expression | ISO | RGD:2544 | 6480464 | Cocaine affects the expression of EGR1 mRNA | CTD | PMID:20187946 more ... |
| cocaine | increases expression | ISO | RGD:2544 | 6480464 | Cocaine results in increased expression of EGR1 mRNA | CTD | PMID:16459018 more ... |
| cocaine | increases expression | ISO | RGD:2544 | 6480464 | Cocaine results in increased expression of EGR1 mRNA | CTD | PMID:9890435 more ... |
| cocaine | increases expression | ISO | RGD:2544 | 6480464 | Cocaine results in increased expression of EGR1 mRNA | CTD | PMID:9890435 more ... |
| cocaine | affects expression | ISO | RGD:2544 | 6480464 | Cocaine affects the expression of EGR1 mRNA | CTD | PMID:17851536 more ... |
| cocaine | increases expression | ISO | RGD:10512 | 6480464 | Cocaine results in increased expression of EGR1 protein | CTD | PMID:16339038 |
| cocaine | multiple interactions | ISO | RGD:2544 | 6480464 | NPPC protein inhibits the reaction [Cocaine results in increased expression of EGR1 mRNA] | CTD | PMID:11860464 |
| cocaine | increases expression | ISO | RGD:2544 | 6480464 | Cocaine results in increased expression of EGR1 protein | CTD | PMID:18311559 |
| cocaine | increases response to substance | ISO | RGD:2544 | 6480464 | EGR1 results in increased susceptibility to Cocaine | CTD | PMID:16738229 |
| cocaine | increases expression | ISO | RGD:2544 | 6480464 | Cocaine results in increased expression of EGR1 mRNA | CTD | PMID:11860464 more ... |
| cocaine | affects expression | ISO | RGD:2544 | 6480464 | Cocaine affects the expression of EGR1 mRNA | CTD | PMID:17851536 more ... |
| cocaine | multiple interactions | ISO | RGD:10512 | 6480464 | Cocaine promotes the reaction [Caffeine results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:10971643 |
| copper atom | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of EGR1 mRNA | CTD | PMID:20971185 |
| copper atom | multiple interactions | ISO | RGD:10512 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of EGR1 mRNA | CTD | PMID:15467011 |
| copper atom | increases expression | ISO | RGD:2544 | 6480464 | Copper deficiency results in increased expression of EGR1 mRNA | CTD | PMID:17418555 |
| copper(0) | multiple interactions | EXP | | 6480464 | [NSC 689534 binds to Copper] which results in increased expression of EGR1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:10512 | 6480464 | [ATP7A gene mutant form results in increased abundance of Copper] which results in increased expression of EGR1 mRNA | CTD | PMID:15467011 |
| copper(0) | increases expression | ISO | RGD:2544 | 6480464 | Copper deficiency results in increased expression of EGR1 mRNA | CTD | PMID:17418555 |
| copper(2+) sulfate | increases expression | EXP | | 6480464 | Copper Sulfate results in increased expression of EGR1 mRNA | CTD | PMID:19549813 |
| copper(II) chloride | affects expression | EXP | | 6480464 | cupric chloride affects the expression of EGR1 mRNA | CTD | PMID:17211630 |
| coumestrol | multiple interactions | EXP | | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of EGR1 mRNA | CTD | PMID:19167446 |
| crocidolite asbestos | increases expression | EXP | | 6480464 | Asbestos, Crocidolite results in increased expression of EGR1 mRNA | CTD | PMID:18687144 |
| curcumin | multiple interactions | EXP | | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [Curcumin results in increased expression of EGR1 protein]; more ... | CTD | PMID:18316600 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of EGR1 mRNA | CTD | PMID:17198877 PMID:18316600 |
| curcumin | increases expression | ISO | RGD:2544 | 6480464 | Curcumin results in increased expression of EGR1 protein | CTD | PMID:18316600 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of EGR1 protein | CTD | PMID:18316600 |
| curcumin | increases expression | EXP | | 6480464 | Curcumin results in increased expression of EGR1 mRNA | CTD | PMID:18316600 PMID:17198877 |
| curcumin | decreases expression | EXP | | 6480464 | Curcumin results in decreased expression of EGR1 mRNA | CTD | PMID:17999991 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA] | CTD | PMID:12690110 |
| cyclophosphamide | increases expression | EXP | | 6480464 | Cyclophosphamide results in increased expression of EGR1 mRNA | CTD | PMID:21527772 |
| cyclophosphamide | increases expression | ISO | RGD:2544 | 6480464 | Cyclophosphamide results in increased expression of EGR1 protein | CTD | PMID:7498375 PMID:9776515 |
| cyclophosphamide | decreases expression | ISO | RGD:10512 | 6480464 | Cyclophosphamide results in decreased expression of EGR1 mRNA | CTD | PMID:21041162 |
| cyclophosphamide | increases expression | ISO | RGD:2544 | 6480464 | Cyclophosphamide results in increased expression of EGR1 protein | CTD | PMID:9776515 PMID:7498375 |
| cycloserine | increases expression | ISO | RGD:2544 | 6480464 | Cycloserine results in increased expression of EGR1 protein | CTD | PMID:19144966 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of EGR1 mRNA | CTD | PMID:20106945 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of EGR1 mRNA | CTD | PMID:20106945 PMID:21632981 |
| cyclosporin A | increases expression | ISO | RGD:2544 | 6480464 | Cyclosporine results in increased expression of EGR1 mRNA | CTD | PMID:21865292 |
| D-glucose | multiple interactions | EXP | | 6480464 | Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:19225232 |
| D-glucose | increases expression | ISO | RGD:10512 | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:17178593 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:19225232 |
| D-penicillamine | increases expression | ISO | RGD:2544 | 6480464 | Penicillamine results in increased expression of EGR1 mRNA | CTD | PMID:19575532 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | ISO | RGD:10512 | 6480464 | SL 327 inhibits the reaction [Tetrahydrocannabinol results in increased expression of EGR1 mRNA] | CTD | PMID:11553284 PMID:12657697 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:10512 | 6480464 | Tetrahydrocannabinol results in increased expression of EGR1 mRNA | CTD | PMID:11553284 more ... |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:10512 | 6480464 | Tetrahydrocannabinol results in increased expression of EGR1 protein | CTD | PMID:11553284 |
| Delta(9)-tetrahydrocannabinol | increases expression | ISO | RGD:2544 | 6480464 | Tetrahydrocannabinol results in increased expression of EGR1 mRNA | CTD | PMID:7919180 |
| Delta(9)-tetrahydrocannabinol | decreases expression | EXP | | 6480464 | Tetrahydrocannabinol results in decreased expression of EGR1 mRNA | CTD | PMID:16039398 |
| Delta(9)-tetrahydrocannabinol | multiple interactions | ISO | RGD:10512 | 6480464 | SL 327 inhibits the reaction [Tetrahydrocannabinol results in increased expression of EGR1 protein] | CTD | PMID:11553284 |
| deoxycholic acid | increases expression | ISO | RGD:10512 | 6480464 | Deoxycholic Acid results in increased expression of EGR1 mRNA; more ... | CTD | PMID:19931294 |
| deoxycholic acid | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 promotes the reaction [Deoxycholic Acid results in increased expression of CSF3 mRNA]; more ... | CTD | PMID:21224055 |
| deoxycholic acid | increases expression | ISO | RGD:10512 | 6480464 | Deoxycholic Acid results in increased expression of EGR1 mRNA; more ... | CTD | PMID:19931294 PMID:21224055 |
| deoxycholic acid | multiple interactions | ISO | RGD:10512 | 6480464 | U 0126 inhibits the reaction [Deoxycholic Acid results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:19931294 |
| desipramine | decreases expression | ISO | RGD:2544 | 6480464 | Desipramine results in decreased expression of EGR1 mRNA | CTD | PMID:7612155 |
| dexamethasone | multiple interactions | ISO | RGD:2544 | 6480464 | Dexamethasone promotes the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] | CTD | PMID:18590720 |
| dexamethasone | multiple interactions | ISO | RGD:2544 | 6480464 | Dexamethasone promotes the reaction [EGR1 protein results in increased expression of PNMT mRNA] | CTD | PMID:8063705 |
| dexamethasone | decreases expression | ISO | RGD:10512 | 6480464 | Dexamethasone results in decreased expression of EGR1 mRNA | CTD | PMID:21041162 |
| diarsenic trioxide | affects expression | EXP | | 6480464 | arsenic trioxide affects the expression of EGR1 mRNA | CTD | PMID:12749819 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of EGR1 mRNA | CTD | PMID:20458559 PMID:22521957 |
| diarsenic trioxide | increases expression | ISO | RGD:10512 | 6480464 | arsenic trioxide results in increased expression of EGR1 mRNA | CTD | PMID:15688020 PMID:15073043 |
| diarsenic trioxide | increases expression | ISO | RGD:10512 | 6480464 | arsenic trioxide results in increased expression of EGR1 mRNA | CTD | PMID:15073043 PMID:15688020 |
| diarsenic trioxide | multiple interactions | ISO | RGD:10512 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one inhibits the reaction [arsenic trioxide results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:15688020 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of EGR1 mRNA | CTD | PMID:20458559 |
| diazoxide | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 mRNA]; more ... | CTD | PMID:15621046 |
| diazoxide | increases expression | ISO | RGD:2544 | 6480464 | Isoproterenol results in increased expression of EGR1 protein | CTD | PMID:15621046 |
| diazoxide | multiple interactions | ISO | RGD:2544 | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein]; more ... | CTD | PMID:15621046 |
| diazoxide | decreases expression | ISO | RGD:10512 | 6480464 | Isoproterenol results in decreased expression of EGR1 mRNA | CTD | PMID:20003209 |
| diazoxide | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA]; more ... | CTD | PMID:10710348 |
| dibutyl phthalate | increases expression | ISO | RGD:10512 | 6480464 | Dibutyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:10512 | 6480464 | Dibutyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:17361019 PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:2544 | 6480464 | Dibutyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:15728792 PMID:21266533 |
| dibutyl phthalate | increases expression | ISO | RGD:2544 | 6480464 | Dibutyl Phthalate results in increased expression of EGR1 mRNA | CTD | PMID:21266533 PMID:15728792 |
| dichlorine | multiple interactions | ISO | RGD:2544 | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of EGR1 mRNA | CTD | PMID:18636392 |
| diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of EGR1 mRNA | CTD | PMID:15509713 |
| diethylstilbestrol | increases expression | ISO | RGD:10512 | 6480464 | Diethylstilbestrol results in increased expression of EGR1 mRNA | CTD | PMID:16636312 |
| diethylstilbestrol | decreases expression | ISO | RGD:10512 | 6480464 | Diethylstilbestrol results in decreased expression of EGR1 mRNA | CTD | PMID:21041162 |
| dimethyl sulfoxide | increases expression | ISO | RGD:2544 | 6480464 | Dimethyl Sulfoxide results in increased expression of EGR1 mRNA | CTD | PMID:22193206 |
| dimethylarsinic acid | increases expression | ISO | RGD:10512 | 6480464 | Cacodylic Acid results in increased expression of EGR1 mRNA | CTD | PMID:15345372 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of EGR1 mRNA | CTD | PMID:17914565 |
| dioxygen | increases expression | ISO | RGD:2544 | 6480464 | Oxygen deficiency results in increased expression of EGR1 mRNA | CTD | PMID:12468449 |
| dioxygen | multiple interactions | ISO | RGD:2544 | 6480464 | 15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of EGR1 protein]; more ... | CTD | PMID:12468449 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of EGR1 mRNA | CTD | PMID:19502547 PMID:17914565 |
| dioxygen | increases expression | EXP | | 6480464 | Oxygen deficiency results in increased expression of EGR1 mRNA | CTD | PMID:17914565 PMID:19502547 |
| diquat | multiple interactions | ISO | RGD:10512 | 6480464 | PROP1 protein affects the reaction [Diquat results in increased expression of EGR1 mRNA] | CTD | PMID:20826540 |
| diquat | increases expression | ISO | RGD:10512 | 6480464 | Diquat results in increased expression of EGR1 mRNA | CTD | PMID:20826540 |
| disodium selenite | increases expression | EXP | | 6480464 | Sodium Selenite results in increased expression of EGR1 mRNA | CTD | PMID:18175754 |
| disodium selenite | increases expression | ISO | RGD:2544 | 6480464 | Sodium Selenite results in increased expression of EGR1 mRNA | CTD | PMID:20067779 |
| disodium selenite | multiple interactions | ISO | RGD:2544 | 6480464 | Acetylcarnitine inhibits the reaction [Sodium Selenite results in increased expression of EGR1 mRNA] | CTD | PMID:20067779 |
| divanadium pentaoxide | affects expression | EXP | | 6480464 | vanadium pentoxide affects the expression of EGR1 mRNA | CTD | PMID:17459161 |
| doxorubicin | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with trichostatin A] results in increased expression of EGR1 mRNA; more ... | CTD | PMID:17330857 |
| doxorubicin | increases expression | ISO | RGD:2544 | 6480464 | Doxorubicin results in increased expression of EGR1 mRNA | CTD | PMID:10625299 |
| doxorubicin | multiple interactions | ISO | RGD:2544 | 6480464 | Doxorubicin promotes the reaction [EGR1 protein binds to ATP2A2 promoter]; more ... | CTD | PMID:10625299 |
| doxorubicin | decreases expression | ISO | RGD:10512 | 6480464 | Doxorubicin results in decreased expression of EGR1 protein | CTD | PMID:12714334 |
| doxorubicin | multiple interactions | ISO | RGD:10512 | 6480464 | [Doxorubicin co-treated with Razoxane] results in decreased expression of EGR1 protein | CTD | PMID:12714334 |
| doxorubicin | affects expression | EXP | | 6480464 | Doxorubicin affects the expression of EGR1 mRNA | CTD | PMID:15205334 |
| elemental selenium | multiple interactions | ISO | RGD:2544 | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA | CTD | PMID:11444866 |
| emodin | multiple interactions | ISO | RGD:2544 | 6480464 | Emodin inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] | CTD | PMID:18590720 |
| estriol | increases expression | ISO | RGD:2544 | 6480464 | Estriol results in increased expression of EGR1 mRNA | CTD | PMID:1717835 |
| ethanol | increases expression | ISO | RGD:10512 | 6480464 | Ethanol results in increased expression of EGR1 mRNA | CTD | PMID:18427989 |
| ethanol | decreases expression | ISO | RGD:10512 | 6480464 | Ethanol results in decreased expression of EGR1 mRNA | CTD | PMID:21955143 |
| ethanol | increases expression | ISO | RGD:2544 | 6480464 | Ethanol results in increased expression of EGR1 protein | CTD | PMID:15234257 |
| ethanol | increases expression | ISO | RGD:2544 | 6480464 | Ethanol results in increased expression of EGR1 mRNA | CTD | PMID:16946407 |
| ethanol | multiple interactions | ISO | RGD:10512 | 6480464 | Naltrexone promotes the reaction [Ethanol results in increased expression of EGR1 mRNA] | CTD | PMID:18427989 |
| eugenol | multiple interactions | ISO | RGD:10512 | 6480464 | [[Eugenol results in increased activity of OLFR73 protein] which results in increased abundance of Cyclic AMP] which results in increased expression of EGR1 mRNA | CTD | PMID:12767924 |
| fluoranthene | increases expression | EXP | | 6480464 | fluoranthene results in increased expression of EGR1 protein | CTD | PMID:15342960 |
| fluoxetine | multiple interactions | ISO | RGD:2544 | 6480464 | [Fluoxetine co-treated with Methylphenidate] results in increased expression of EGR1 mRNA | CTD | PMID:21753012 |
| fluoxetine | multiple interactions | ISO | RGD:2544 | 6480464 | Fluoxetine promotes the reaction [Methylphenidate results in increased expression of EGR1 mRNA] | CTD | PMID:19931852 |
| fluoxetine | increases expression | ISO | RGD:2544 | 6480464 | Fluoxetine results in increased expression of EGR1 mRNA | CTD | PMID:21753012 |
| folic acid | multiple interactions | ISO | RGD:10512 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EGR1 gene | CTD | PMID:20938992 |
| formaldehyde | increases expression | EXP | | 6480464 | Formaldehyde results in increased expression of EGR1 mRNA | CTD | PMID:20655997 |
| furan | decreases expression | ISO | RGD:10512 | 6480464 | furan results in decreased expression of EGR1 mRNA | CTD | PMID:20194422 |
| gamma-hexachlorocyclohexane | increases expression | ISO | RGD:2544 | 6480464 | Lindane results in increased expression of EGR1 mRNA | CTD | PMID:17785943 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of EGR1 mRNA | CTD | PMID:15257099 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of EGR1 mRNA | CTD | PMID:15257099 PMID:23019147 |
| genistein | increases expression | ISO | RGD:2544 | 6480464 | Genistein results in increased expression of EGR1 mRNA | CTD | PMID:12075121 |
| glucose | multiple interactions | EXP | | 6480464 | Glucose promotes the reaction [AGT protein results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:19225232 |
| glucose | increases expression | ISO | RGD:10512 | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:17178593 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of EGR1 mRNA | CTD | PMID:19225232 |
| haloperidol | increases expression | ISO | RGD:2544 | 6480464 | Haloperidol results in increased expression of EGR1 mRNA | CTD | PMID:18208916 more ... |
| haloperidol | multiple interactions | ISO | RGD:10512 | 6480464 | OPRM1 protein inhibits the reaction [Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]] | CTD | PMID:20184921 |
| haloperidol | increases expression | ISO | RGD:2544 | 6480464 | Haloperidol results in increased expression of EGR1 mRNA | CTD | PMID:12243769 more ... |
| haloperidol | increases expression | ISO | RGD:2544 | 6480464 | Haloperidol results in increased expression of EGR1 mRNA | CTD | PMID:19695244 more ... |
| haloperidol | increases expression | ISO | RGD:2544 | 6480464 | Haloperidol results in increased expression of EGR1 mRNA | CTD | PMID:19695244 more ... |
| haloperidol | increases expression | ISO | RGD:2544 | 6480464 | Haloperidol results in increased expression of EGR1 protein | CTD | PMID:17913375 |
| haloperidol | affects expression | ISO | RGD:2544 | 6480464 | Haloperidol affects the expression of EGR1 protein | CTD | PMID:17028028 |
| hydrogen peroxide | affects expression | EXP | | 6480464 | Hydrogen Peroxide affects the expression of EGR1 mRNA | CTD | PMID:20044591 |
| hydrogen peroxide | increases expression | ISO | RGD:10512 | 6480464 | Hydrogen Peroxide results in increased expression of EGR1 mRNA | CTD | PMID:19786089 |
| hydrogen peroxide | multiple interactions | ISO | RGD:10512 | 6480464 | PD 98059 inhibits the reaction [Hydrogen Peroxide results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:19786089 |
| hydrogen peroxide | increases expression | ISO | RGD:2544 | 6480464 | Hydrogen Peroxide results in increased expression of EGR1 mRNA | CTD | PMID:10625299 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of EGR1 mRNA | CTD | PMID:12414654 |
| hydroxytyrosol | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [3,4-dihydroxyphenylethanol results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:12482581 |
| hydroxytyrosol | increases expression | EXP | | 6480464 | 3,4-dihydroxyphenylethanol results in increased expression of EGR1 mRNA; more ... | CTD | PMID:12482581 |
| indole-3-methanol | affects expression | ISO | RGD:2544 | 6480464 | indole-3-carbinol affects the expression of EGR1 mRNA | CTD | PMID:21396975 |
| indomethacin | multiple interactions | EXP | | 6480464 | Indomethacin inhibits the reaction [VEGFA protein results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:11595463 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of EGR1 mRNA | CTD | PMID:15509713 PMID:16227405 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of EGR1 protein | CTD | PMID:16227405 |
| indomethacin | increases expression | EXP | | 6480464 | Indomethacin results in increased expression of EGR1 mRNA | CTD | PMID:16227405 PMID:15509713 |
| ionomycin | multiple interactions | EXP | | 6480464 | [Ionomycin results in increased abundance of Calcium] which results in increased expression of EGR1 protein | CTD | PMID:12517959 |
| iron atom | increases expression | ISO | RGD:2544 | 6480464 | Iron deficiency results in increased expression of EGR1 mRNA | CTD | PMID:16629162 |
| isoprenaline | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 protein]; more ... | CTD | PMID:15621046 |
| isoprenaline | increases expression | ISO | RGD:2544 | 6480464 | Isoproterenol results in increased expression of EGR1 protein | CTD | PMID:15621046 |
| isoprenaline | multiple interactions | ISO | RGD:2544 | 6480464 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein]; more ... | CTD | PMID:15621046 |
| isoprenaline | decreases expression | ISO | RGD:10512 | 6480464 | Isoproterenol results in decreased expression of EGR1 mRNA | CTD | PMID:20003209 |
| isoprenaline | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA]; more ... | CTD | PMID:10710348 |
| juglone | multiple interactions | EXP | | 6480464 | juglone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein] | CTD | PMID:20479004 |
| kainic acid | decreases expression | ISO | RGD:10512 | 6480464 | Kainic Acid results in decreased expression of EGR1 mRNA | CTD | PMID:17997037 |
| kainic acid | affects expression | ISO | RGD:2544 | 6480464 | Kainic Acid affects the expression of EGR1 mRNA | CTD | PMID:19700661 |
| kojic acid | multiple interactions | ISO | RGD:2544 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA | CTD | PMID:18544905 |
| L-methionine | multiple interactions | ISO | RGD:10512 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of EGR1 gene | CTD | PMID:20938992 |
| lanthanum atom | decreases expression | ISO | RGD:2544 | 6480464 | Lanthanum results in decreased expression of EGR1 mRNA | CTD | PMID:21695898 |
| lead diacetate | decreases expression | ISO | RGD:2544 | 6480464 | lead acetate results in decreased expression of EGR1 mRNA | CTD | PMID:22641619 |
| lead(0) | increases expression | ISO | RGD:2544 | 6480464 | Lead results in increased expression of EGR1 mRNA | CTD | PMID:10693946 |
| lead(0) | increases activity | ISO | RGD:2544 | 6480464 | Lead results in increased activity of EGR1 protein | CTD | PMID:10693946 |
| luteolin | increases expression | EXP | | 6480464 | Luteolin results in increased expression of EGR1 mRNA | CTD | PMID:19397994 |
| menadione | affects expression | EXP | | 6480464 | Vitamin K 3 affects the expression of EGR1 mRNA | CTD | PMID:20044591 |
| menadione | increases expression | EXP | | 6480464 | Vitamin K 3 results in increased expression of EGR1 mRNA | CTD | PMID:12414654 |
| metformin | increases expression | ISO | RGD:2544 | 6480464 | Metformin results in increased expression of EGR1 mRNA | CTD | PMID:19664596 |
| methamphetamine | multiple interactions | ISO | RGD:2544 | 6480464 | CTAP octapeptide inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA] | CTD | PMID:20298714 |
| methamphetamine | increases expression | ISO | RGD:10512 | 6480464 | Methamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:20184921 |
| methamphetamine | multiple interactions | ISO | RGD:10512 | 6480464 | Haloperidol inhibits the reaction [Methamphetamine results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:20184921 |
| methamphetamine | increases expression | ISO | RGD:2544 | 6480464 | Methamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:11754491 more ... |
| methamphetamine | increases expression | ISO | RGD:2544 | 6480464 | Methamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:15644446 more ... |
| methamphetamine | increases expression | ISO | RGD:2544 | 6480464 | Methamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:20298714 more ... |
| methamphetamine | increases expression | ISO | RGD:2544 | 6480464 | Methamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:15644446 more ... |
| methamphetamine | increases expression | ISO | RGD:2544 | 6480464 | Methamphetamine results in increased expression of EGR1 mRNA | CTD | PMID:11754491 more ... |
| methotrexate | affects expression | ISO | RGD:10512 | 6480464 | Methotrexate affects the expression of EGR1 mRNA | CTD | PMID:18502557 |
| methyl methanesulfonate | increases expression | EXP | | 6480464 | Methyl Methanesulfonate results in increased expression of EGR1 mRNA | CTD | PMID:21527772 |
| methylarsonic acid | increases expression | ISO | RGD:10512 | 6480464 | monomethylarsonic acid results in increased expression of EGR1 mRNA | CTD | PMID:15345372 |
| methylmercury(1+) | multiple interactions | ISO | RGD:2544 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of EGR1 mRNA | CTD | PMID:17905399 |
| methylphenidate | increases expression | ISO | RGD:2544 | 6480464 | Methylphenidate results in increased expression of EGR1 mRNA | CTD | PMID:16549270 |
| methylphenidate | increases expression | ISO | RGD:2544 | 6480464 | Methylphenidate results in increased expression of EGR1 mRNA | CTD | PMID:16549270 more ... |
| methylphenidate | increases expression | ISO | RGD:2544 | 6480464 | Methylphenidate results in increased expression of EGR1 mRNA | CTD | PMID:19931852 more ... |
| methylphenidate | multiple interactions | ISO | RGD:2544 | 6480464 | Fluoxetine promotes the reaction [Methylphenidate results in increased expression of EGR1 mRNA] | CTD | PMID:19931852 |
| methylphenidate | increases expression | ISO | RGD:2544 | 6480464 | Methylphenidate results in increased expression of EGR1 mRNA | CTD | PMID:21753012 more ... |
| methylphenidate | increases expression | ISO | RGD:2544 | 6480464 | Methylphenidate results in increased expression of EGR1 mRNA | CTD | PMID:16549270 PMID:21753012 |
| methylphenidate | multiple interactions | ISO | RGD:2544 | 6480464 | [Fluoxetine co-treated with Methylphenidate] results in increased expression of EGR1 mRNA | CTD | PMID:21753012 |
| methylphenidate | multiple interactions | ISO | RGD:2544 | 6480464 | SCH 23390 inhibits the reaction [Methylphenidate results in increased expression of EGR1 mRNA] | CTD | PMID:16549270 |
| methylphenidate | multiple interactions | ISO | RGD:2544 | 6480464 | Methylphenidate promotes the reaction [Amphetamine results in increased expression of EGR1 mRNA] | CTD | PMID:20020108 |
| microcystin-LR | increases expression | ISO | RGD:10512 | 6480464 | cyanoginosin LR results in increased expression of EGR1 mRNA | CTD | PMID:17383702 |
| mitomycin C | affects response to substance | EXP | | 6480464 | EGR1 protein affects the susceptibility to Mitomycin | CTD | PMID:16217747 |
| mitomycin C | increases expression | EXP | | 6480464 | Mitomycin results in increased expression of EGR1 mRNA | CTD | PMID:12760830 |
| mitoxantrone | affects response to substance | EXP | | 6480464 | EGR1 protein affects the susceptibility to Mitoxantrone | CTD | PMID:16217747 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:2544 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of EGR1 mRNA | CTD | PMID:16809437 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:10512 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
| monocrotaline | multiple interactions | ISO | RGD:10512 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA | CTD | PMID:21224054 |
| morphine | increases expression | ISO | RGD:10512 | 6480464 | Morphine results in increased expression of EGR1 mRNA | CTD | PMID:21955143 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2544 | 6480464 | Acetylcysteine inhibits the reaction [Doxorubicin results in increased expression of EGR1 mRNA] | CTD | PMID:10625299 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:2544 | 6480464 | Acetylcysteine inhibits the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA] | CTD | PMID:19010381 |
| N-methyl-4-phenylpyridinium | decreases expression | ISO | RGD:10512 | 6480464 | 1-Methyl-4-phenylpyridinium results in decreased expression of EGR1 mRNA | CTD | PMID:17475336 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | ISO | RGD:10512 | 6480464 | [Methylnitronitrosoguanidine co-treated with Cadmium Chloride] results in increased expression of EGR1 mRNA | CTD | PMID:19840844 |
| N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of EGR1 mRNA | CTD | PMID:21527772 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:10512 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of EGR1 mRNA] | CTD | PMID:17854601 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:2544 | 6480464 | Diethylnitrosamine results in increased expression of EGR1 mRNA | CTD | PMID:19638242 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:10512 | 6480464 | Diethylnitrosamine results in increased expression of EGR1 mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2544 | 6480464 | [Diethylnitrosamine co-treated with kojic acid co-treated with Diethylnitrosamine] results in increased expression of EGR1 mRNA | CTD | PMID:18544905 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:2544 | 6480464 | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of EGR1 mRNA | CTD | PMID:18164116 |
| naltrexone | multiple interactions | ISO | RGD:10512 | 6480464 | Naltrexone promotes the reaction [Ethanol results in increased expression of EGR1 mRNA] | CTD | PMID:18427989 |
| naltrexone | increases expression | ISO | RGD:10512 | 6480464 | Naltrexone results in increased expression of EGR1 mRNA | CTD | PMID:18427989 |
| nickel sulfate | increases expression | EXP | | 6480464 | nickel sulfate results in increased expression of EGR1 mRNA | CTD | PMID:16780908 |
| nimodipine | multiple interactions | ISO | RGD:10512 | 6480464 | Nimodipine inhibits the reaction [Zinc results in increased expression of EGR1 protein] | CTD | PMID:10428039 |
| NS-398 | multiple interactions | EXP | | 6480464 | N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [VEGFA protein results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:11595463 |
| O-methyleugenol | increases expression | ISO | RGD:10512 | 6480464 | methyleugenol results in increased expression of EGR1 mRNA | CTD | PMID:15618236 |
| oxazepam | decreases expression | ISO | RGD:10512 | 6480464 | Oxazepam results in decreased expression of EGR1 mRNA | CTD | PMID:15618236 |
| ozone | multiple interactions | ISO | RGD:2544 | 6480464 | [Ozone co-treated with Chlorine] results in increased expression of EGR1 mRNA | CTD | PMID:18636392 |
| ozone | increases expression | ISO | RGD:2544 | 6480464 | Ozone results in increased expression of EGR1 mRNA | CTD | PMID:16716893 |
| paracetamol | multiple interactions | ISO | RGD:10512 | 6480464 | [Clofibrate co-treated with Acetaminophen] affects the expression of EGR1 mRNA; more ... | CTD | PMID:17585979 |
| paracetamol | increases expression | ISO | RGD:10512 | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:11752693 more ... |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | ISO | RGD:10512 | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:20363829 more ... |
| paracetamol | increases expression | ISO | RGD:10512 | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:12540782 more ... |
| paracetamol | increases expression | ISO | RGD:10512 | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:11752693 more ... |
| paracetamol | affects expression | ISO | RGD:10512 | 6480464 | Acetaminophen affects the expression of EGR1 mRNA | CTD | PMID:17562736 PMID:15606129 |
| paracetamol | affects expression | ISO | RGD:10512 | 6480464 | Acetaminophen affects the expression of EGR1 mRNA | CTD | PMID:15606129 PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:2544 | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:17202762 |
| paracetamol | increases expression | ISO | RGD:10512 | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:12958197 more ... |
| paracetamol | multiple interactions | ISO | RGD:10512 | 6480464 | O(2)-vinyl-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate inhibits the reaction [Acetaminophen results in increased expression of EGR1 mRNA] | CTD | PMID:12540782 |
| paracetamol | increases expression | ISO | RGD:10512 | 6480464 | Acetaminophen results in increased expression of EGR1 mRNA | CTD | PMID:12540782 more ... |
| paraquat | increases expression | EXP | | 6480464 | Paraquat results in increased expression of EGR1 mRNA | CTD | PMID:20883675 |
| permethrin | increases expression | ISO | RGD:2544 | 6480464 | Permethrin results in increased expression of EGR1 mRNA | CTD | PMID:19017407 |
| phenanthrene | increases expression | EXP | | 6480464 | phenanthrene results in increased expression of EGR1 protein | CTD | PMID:15342960 |
| phenobarbital | decreases expression | ISO | RGD:10512 | 6480464 | Phenobarbital results in decreased expression of EGR1 mRNA | CTD | PMID:19270015 |
| phenobarbital | decreases expression | ISO | RGD:10512 | 6480464 | Phenobarbital results in decreased expression of EGR1 mRNA | CTD | PMID:19270015 PMID:23091169 |
| phenylephrine | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of ACTA1 mRNA]; more ... | CTD | PMID:10710348 |
| phenylephrine | increases expression | ISO | RGD:2544 | 6480464 | Phenylephrine results in increased expression of EGR1 | CTD | PMID:7905536 |
| phenylephrine | increases expression | ISO | RGD:2544 | 6480464 | Phenylephrine results in increased expression of EGR1 mRNA | CTD | PMID:10779383 |
| phenylephrine | multiple interactions | ISO | RGD:2544 | 6480464 | Phenylephrine promotes the reaction [EGR1 protein binds to FGF2 promoter] | CTD | PMID:10779383 |
| phenylephrine | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 protein affects the reaction [[Isoproterenol co-treated with Phenylephrine] results in increased expression of SLC8A1 mRNA]; more ... | CTD | PMID:15621046 |
| phenytoin | multiple interactions | ISO | RGD:10512 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA | CTD | PMID:21224054 |
| phorbol 13-acetate 12-myristate | multiple interactions | EXP | | 6480464 | EGR1 protein promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MAP1LC3B protein]; more ... | CTD | PMID:20479004 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA | CTD | PMID:10739673 more ... |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10512 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA | CTD | PMID:15920718 PMID:19945525 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:2544 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA | CTD | PMID:10693946 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein | CTD | PMID:20479004 PMID:10739673 |
| phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:2544 | 6480464 | Tetradecanoylphorbol Acetate promotes the reaction [EGR1 protein binds to FGF2 promoter] | CTD | PMID:10779383 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 protein | CTD | PMID:10739673 PMID:20479004 |
| phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:10512 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA | CTD | PMID:15920718 |
| phorbol 13-acetate 12-myristate | increases expression | EXP | | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of EGR1 mRNA | CTD | PMID:10739673 PMID:10779383 |
| phosgene | affects expression | ISO | RGD:10512 | 6480464 | Phosgene affects the expression of EGR1 mRNA | CTD | PMID:16300373 |
| pirenzepine | multiple interactions | ISO | RGD:2544 | 6480464 | Pirenzepine inhibits the reaction [Pilocarpine results in increased expression of EGR1 mRNA] | CTD | PMID:7968354 |
| pirinixic acid | increases expression | ISO | RGD:2544 | 6480464 | pirinixic acid results in increased expression of EGR1 mRNA | CTD | PMID:19162173 |
| pirinixic acid | increases expression | ISO | RGD:10512 | 6480464 | pirinixic acid results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
| pirinixic acid | multiple interactions | ISO | RGD:10512 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of EGR1 mRNA | CTD | PMID:19710929 |
| potassium atom | increases expression | ISO | RGD:2544 | 6480464 | Potassium results in increased expression of EGR1 mRNA | CTD | PMID:10693946 |
| potassium cyanide | multiple interactions | ISO | RGD:2544 | 6480464 | Potassium Cyanide inhibits the reaction [Adenosine Triphosphate results in increased expression of EGR1 mRNA] | CTD | PMID:10723097 |
| potassium cyanide | increases expression | ISO | RGD:2544 | 6480464 | Potassium Cyanide results in increased expression of EGR1 mRNA | CTD | PMID:10723097 |
| potassium dichromate | increases expression | EXP | | 6480464 | Potassium Dichromate results in increased expression of EGR1 mRNA | CTD | PMID:18332044 |
| pregnenolone 16alpha-carbonitrile | increases expression | ISO | RGD:2544 | 6480464 | Pregnenolone Carbonitrile results in increased expression of EGR1 mRNA | CTD | PMID:19162173 |
| progesterone | multiple interactions | EXP | | 6480464 | [Progesterone co-treated with Estradiol] results in decreased expression of EGR1 mRNA | CTD | PMID:17404688 |
| propiconazole | decreases expression | ISO | RGD:10512 | 6480464 | propiconazole results in decreased expression of EGR1 mRNA | CTD | PMID:21278054 |
| propranolol | multiple interactions | ISO | RGD:2544 | 6480464 | Propranolol inhibits the reaction [Isoproterenol results in increased expression of EGR1 protein] | CTD | PMID:15621046 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of EGR1 mRNA | CTD | PMID:15309432 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of EGR1 mRNA | CTD | PMID:21632981 |
| quercetin | increases expression | ISO | RGD:2544 | 6480464 | Quercetin results in increased expression of EGR1 mRNA; more ... | CTD | PMID:19798679 |
| quercetin | multiple interactions | ISO | RGD:2544 | 6480464 | Quercetin promotes the reaction [EGR1 protein binds to GCLC promoter] | CTD | PMID:19798679 |
| quinolin-8-ol | multiple interactions | ISO | RGD:10512 | 6480464 | [cupric acetate co-treated with Oxyquinoline] results in increased expression of EGR1 mRNA | CTD | PMID:10487485 |
| raloxifene | multiple interactions | EXP | | 6480464 | [Raloxifene co-treated with ESR2 protein] results in increased expression of EGR1 mRNA | CTD | PMID:19059307 |
| ranitidine | multiple interactions | ISO | RGD:2544 | 6480464 | [Lipopolysaccharides co-treated with Ranitidine] results in increased expression of EGR1 mRNA | CTD | PMID:16401727 |
| ranitidine | multiple interactions | ISO | RGD:2544 | 6480464 | Ranitidine promotes the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA] | CTD | PMID:16415329 |
| razoxane | multiple interactions | ISO | RGD:10512 | 6480464 | [Doxorubicin co-treated with Razoxane] results in decreased expression of EGR1 protein | CTD | PMID:12714334 |
| razoxane | decreases expression | ISO | RGD:10512 | 6480464 | Razoxane results in decreased expression of EGR1 protein | CTD | PMID:12714334 |
| reserpine | multiple interactions | ISO | RGD:2544 | 6480464 | eticlopride inhibits the reaction [[Reserpine co-treated with Levodopa] results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:9890435 |
| reserpine | multiple interactions | ISO | RGD:2544 | 6480464 | Reserpine promotes the reaction [Dextroamphetamine results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:1347779 |
| reserpine | increases expression | ISO | RGD:2544 | 6480464 | Reserpine results in increased expression of EGR1 protein | CTD | PMID:8063705 |
| reserpine | increases expression | ISO | RGD:2544 | 6480464 | Reserpine results in increased expression of EGR1 mRNA | CTD | PMID:9729266 |
| reserpine | multiple interactions | ISO | RGD:2544 | 6480464 | Quinpirole inhibits the reaction [Reserpine results in increased expression of EGR1 mRNA] | CTD | PMID:9729266 |
| resveratrol | affects expression | ISO | RGD:2544 | 6480464 | resveratrol affects the expression of EGR1 mRNA | CTD | PMID:21736731 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:12482581 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 protein | CTD | PMID:12482581 |
| resveratrol | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:12482581 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 protein | CTD | PMID:12482581 PMID:21205742 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [[EGR1 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA]; more ... | CTD | PMID:21205742 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:12482581 more ... |
| resveratrol | increases expression | ISO | RGD:10512 | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:16081268 |
| resveratrol | increases expression | ISO | RGD:2544 | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:16280599 |
| resveratrol | multiple interactions | ISO | RGD:10512 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of EGR1 mRNA] | CTD | PMID:21736731 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:12482581 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 protein | CTD | PMID:12482581 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:12482581 PMID:12690110 |
| resveratrol | affects response to substance | EXP | | 6480464 | EGR1 protein affects the susceptibility to resveratrol | CTD | PMID:12690110 |
| resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of EGR1 protein | CTD | PMID:12690110 |
| resveratrol | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:12690110 |
| riddelliine | increases expression | ISO | RGD:2544 | 6480464 | riddelliine results in increased expression of EGR1 mRNA | CTD | PMID:18047727 |
| rifampicin | multiple interactions | ISO | RGD:10512 | 6480464 | [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in decreased expression of EGR1 mRNA | CTD | PMID:21224054 |
| rifampicin | multiple interactions | EXP | | 6480464 | [Rifampin co-treated with NR1I2 protein] results in increased expression of EGR1 mRNA | CTD | PMID:21127053 |
| risperidone | decreases expression | ISO | RGD:2544 | 6480464 | Risperidone results in decreased expression of EGR1 protein | CTD | PMID:17028028 |
| ropinirole | decreases expression | ISO | RGD:2544 | 6480464 | ropinirole results in decreased expression of EGR1 mRNA | CTD | PMID:20452347 |
| rosiglitazone | multiple interactions | ISO | RGD:10512 | 6480464 | rosiglitazone inhibits the reaction [Bleomycin results in increased expression of EGR1 mRNA] | CTD | PMID:19147827 |
| rosiglitazone | decreases expression | ISO | RGD:2544 | 6480464 | rosiglitazone results in decreased expression of EGR1 mRNA | CTD | PMID:17394460 PMID:21515302 |
| rosiglitazone | decreases expression | ISO | RGD:2544 | 6480464 | rosiglitazone results in decreased expression of EGR1 mRNA | CTD | PMID:17394460 |
| rotenone | increases expression | ISO | RGD:2544 | 6480464 | Rotenone results in increased expression of EGR1 mRNA | CTD | PMID:19664596 |
| S-butyl-DL-homocysteine (S,R)-sulfoximine | multiple interactions | ISO | RGD:2544 | 6480464 | Buthionine Sulfoximine promotes the reaction [Cadmium Chloride results in increased expression of EGR1 mRNA] | CTD | PMID:19010381 |
| scopolamine | decreases expression | ISO | RGD:2544 | 6480464 | Scopolamine Hydrobromide results in decreased expression of EGR1 mRNA | CTD | PMID:17540011 |
| scopolamine | decreases expression | ISO | RGD:2544 | 6480464 | Scopolamine Hydrobromide results in decreased expression of EGR1 mRNA | CTD | PMID:17540011 PMID:8861055 |
| scopolamine | decreases expression | ISO | RGD:2544 | 6480464 | Scopolamine Hydrobromide results in decreased expression of EGR1 mRNA | CTD | PMID:8861055 PMID:17540011 |
| scopolamine | multiple interactions | ISO | RGD:2544 | 6480464 | Scopolamine Hydrobromide affects the reaction [SK&F 82958 results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:8861055 |
| selenium atom | multiple interactions | ISO | RGD:2544 | 6480464 | [Selenium deficiency co-treated with Vitamin E deficiency] results in increased expression of EGR1 mRNA | CTD | PMID:11444866 |
| sevoflurane | affects expression | ISO | RGD:2544 | 6480464 | sevoflurane affects the expression of EGR1 mRNA | CTD | PMID:15967596 |
| silicon dioxide | increases expression | ISO | RGD:10512 | 6480464 | Silicon Dioxide results in increased expression of EGR1 mRNA | CTD | PMID:19073995 |
| simvastatin | decreases expression | ISO | RGD:10512 | 6480464 | Simvastatin results in decreased expression of EGR1 protein | CTD | PMID:12818400 |
| sodium atom | multiple interactions | EXP | | 6480464 | [EGR1 protein results in increased chemical synthesis of and results in increased activity of Reactive Oxygen Species] which results in decreased transport of Sodium | CTD | PMID:12517959 |
| sodium azide | multiple interactions | ISO | RGD:2544 | 6480464 | Sodium Azide inhibits the reaction [Adenosine Triphosphate results in increased expression of EGR1 mRNA] | CTD | PMID:10723097 |
| sodium chloride | increases expression | ISO | RGD:2544 | 6480464 | Sodium Chloride results in increased expression of EGR1 | CTD | PMID:16280599 |
| sodium dichromate | decreases expression | EXP | | 6480464 | sodium bichromate results in decreased expression of EGR1 mRNA | CTD | PMID:12760830 |
| sodium dichromate | increases expression | ISO | RGD:2544 | 6480464 | sodium bichromate results in increased expression of EGR1 mRNA | CTD | PMID:22561333 |
| tacrolimus hydrate | increases expression | ISO | RGD:2544 | 6480464 | Tacrolimus results in increased expression of EGR1 mRNA | CTD | PMID:21865292 |
| tamoxifen | multiple interactions | EXP | | 6480464 | [Tamoxifen co-treated with ESR2 protein] results in increased expression of EGR1 mRNA | CTD | PMID:19059307 |
| tamoxifen | multiple interactions | ISO | RGD:2544 | 6480464 | [bexarotene co-treated with Tamoxifen] results in decreased expression of EGR1 mRNA | CTD | PMID:17630414 |
| tamoxifen | affects expression | ISO | RGD:10512 | 6480464 | Tamoxifen affects the expression of EGR1 mRNA | CTD | PMID:20937368 |
| taurocholic acid | multiple interactions | ISO | RGD:10512 | 6480464 | EGR1 promotes the reaction [Taurocholic Acid results in increased expression of CCL2 mRNA]; more ... | CTD | PMID:21224055 |
| taurocholic acid | increases expression | ISO | RGD:10512 | 6480464 | Taurocholic Acid results in increased expression of EGR1 mRNA; more ... | CTD | PMID:21224055 |
| tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of EGR1 mRNA | CTD | PMID:12414654 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of EGR1 mRNA | CTD | PMID:21592394 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of EGR1 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | ISO | RGD:10512 | 6480464 | Carbon Tetrachloride results in increased expression of EGR1 mRNA | CTD | PMID:15056808 |
| tetrachloromethane | multiple interactions | ISO | RGD:10512 | 6480464 | PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of EGR1 mRNA] | CTD | PMID:16006527 |
| thapsigargin | increases expression | ISO | RGD:10512 | 6480464 | Thapsigargin results in increased expression of EGR1 mRNA | CTD | PMID:8764118 |
| thapsigargin | increases expression | EXP | | 6480464 | Thapsigargin results in increased expression of EGR1 mRNA | CTD | PMID:21694771 |
| titanium dioxide | decreases expression | ISO | RGD:10512 | 6480464 | titanium dioxide results in decreased expression of EGR1 mRNA | CTD | PMID:23409001 |
| tocopherol | decreases activity | EXP | | 6480464 | Tocopherols results in decreased activity of EGR1 protein | CTD | PMID:15878867 |
| trans-resveratrol | affects expression | ISO | RGD:2544 | 6480464 | resveratrol affects the expression of EGR1 mRNA | CTD | PMID:21736731 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:12482581 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 protein | CTD | PMID:12482581 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:12482581 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 protein | CTD | PMID:12482581 PMID:21205742 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [[EGR1 protein binds to ATF3 promoter] which results in increased expression of ATF3 mRNA]; more ... | CTD | PMID:21205742 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:12482581 more ... |
| trans-resveratrol | increases expression | ISO | RGD:10512 | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:16081268 |
| trans-resveratrol | increases expression | ISO | RGD:2544 | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:16280599 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 mRNA | CTD | PMID:12482581 more ... |
| trans-resveratrol | multiple interactions | ISO | RGD:10512 | 6480464 | resveratrol inhibits the reaction [TNF protein results in increased expression of EGR1 mRNA] | CTD | PMID:21736731 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of EGR1 protein | CTD | PMID:12482581 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:12482581 PMID:12690110 |
| trans-resveratrol | affects response to substance | EXP | | 6480464 | EGR1 protein affects the susceptibility to resveratrol | CTD | PMID:12690110 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [resveratrol results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:12690110 |
| trans-resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of EGR1 protein | CTD | PMID:12690110 |
| trichloroethene | multiple interactions | ISO | RGD:2544 | 6480464 | [Benzene co-treated with methylmercury II co-treated with Trichloroethylene] results in decreased expression of EGR1 mRNA | CTD | PMID:17905399 |
| trichostatin A | multiple interactions | EXP | | 6480464 | [Doxorubicin co-treated with trichostatin A] results in increased expression of EGR1 mRNA; more ... | CTD | PMID:17330857 |
| trichostatin A | affects expression | EXP | | 6480464 | trichostatin A affects the expression of EGR1 protein; more ... | CTD | PMID:18801729 |
| trichostatin A | multiple interactions | EXP | | 6480464 | EGR1 protein affects the reaction [trichostatin A affects the expression of GDF15 mRNA] | CTD | PMID:18801729 |
| troglitazone | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [troglitazone results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:16079301 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of EGR1 protein | CTD | PMID:12475986 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of EGR1 mRNA | CTD | PMID:16079301 PMID:15064713 |
| troglitazone | multiple interactions | ISO | RGD:2544 | 6480464 | troglitazone inhibits the reaction [Oxygen deficiency results in increased expression of and results in increased activity of EGR1 protein]; more ... | CTD | PMID:12468449 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of EGR1 protein | CTD | PMID:12475986 more ... |
| troglitazone | decreases expression | ISO | RGD:10512 | 6480464 | troglitazone results in decreased expression of EGR1 protein; more ... | CTD | PMID:12468449 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of EGR1 protein | CTD | PMID:21461570 more ... |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of EGR1 protein | CTD | PMID:16079301 more ... |
| troglitazone | increases activity | EXP | | 6480464 | troglitazone results in increased activity of EGR1 protein | CTD | PMID:12475986 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of EGR1 mRNA | CTD | PMID:15064713 PMID:16079301 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of EGR1 mRNA | CTD | PMID:19631733 |
| troglitazone | multiple interactions | EXP | | 6480464 | PD 98059 inhibits the reaction [troglitazone results in increased expression of EGR1 protein]; more ... | CTD | PMID:12475986 |
| troglitazone | multiple interactions | EXP | | 6480464 | [EGR1 protein binds to GDF15 promoter] affects the reaction [troglitazone results in increased expression of GDF15] | CTD | PMID:14662774 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of EGR1 mRNA; more ... | CTD | PMID:16079301 |
| ursodeoxycholic acid | multiple interactions | ISO | RGD:2544 | 6480464 | Ursodeoxycholic Acid inhibits the reaction [1-Naphthylisothiocyanate results in increased expression of EGR1 mRNA] | CTD | PMID:18590720 |
| valproic acid | affects expression | ISO | RGD:10512 | 6480464 | Valproic Acid affects the expression of EGR1 mRNA | CTD | PMID:17963808 |
| valproic acid | increases expression | ISO | RGD:10512 | 6480464 | Valproic Acid results in increased expression of EGR1 mRNA | CTD | PMID:20546886 |
| valsartan | multiple interactions | EXP | | 6480464 | valsartan inhibits the reaction [AGT protein results in increased expression of EGR1 mRNA]; more ... | CTD | PMID:19225232 |
| vancomycin | increases expression | ISO | RGD:10512 | 6480464 | Vancomycin results in increased expression of EGR1 mRNA | CTD | PMID:18930951 |
| vincristine | increases expression | EXP | | 6480464 | Vincristine results in increased expression of EGR1 mRNA | CTD | PMID:12706485 |
| xanomeline | increases expression | ISO | RGD:2544 | 6480464 | xanomeline results in increased expression of EGR1 mRNA | CTD | PMID:11313039 |
| zinc atom | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of EGR1 protein | CTD | PMID:12107072 |
| zinc atom | increases expression | ISO | RGD:10512 | 6480464 | Zinc results in increased expression of EGR1 protein; more ... | CTD | PMID:10428039 |
| zinc atom | multiple interactions | ISO | RGD:10512 | 6480464 | Nimodipine inhibits the reaction [Zinc results in increased expression of EGR1 protein]; more ... | CTD | PMID:10428039 |
| zinc atom | increases expression | EXP | | 6480464 | Zinc results in increased expression of EGR1 protein | CTD | PMID:12107072 |
| zinc atom | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of EGR1 mRNA | CTD | PMID:18593933 |
| zinc(0) | decreases expression | EXP | | 6480464 | Zinc deficiency results in decreased expression of EGR1 protein | CTD | PMID:12107072 |
| zinc(0) | multiple interactions | ISO | RGD:10512 | 6480464 | Nimodipine inhibits the reaction [Zinc results in increased expression of EGR1 protein]; more ... | CTD | PMID:10428039 |
| zinc(0) | increases expression | ISO | RGD:10512 | 6480464 | Zinc results in increased expression of EGR1 protein; more ... | CTD | PMID:10428039 |
| zinc(0) | increases expression | EXP | | 6480464 | Zinc results in increased expression of EGR1 protein | CTD | PMID:12107072 |
| zinc(0) | multiple interactions | EXP | | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of EGR1 mRNA | CTD | PMID:18593933 |
| zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of EGR1 mRNA | CTD | PMID:20977926 |